A Phase 1, Open-label, Randomized, 3-period Crossover Taste Assessment Study to Characterize the Palatability of SHP429 When the Contents Are Sprinkled Onto Soft Foods or Emptied Into a Cup and Administered With Water in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2015
Price : $35 *
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Pharmacodynamics
- Sponsors Shire
- 03 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 02 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 06 May 2014 New trial record